Template talk:Lymphocytic immune system

This is the talk page for discussing improvements to the Lymphocytic immune system template.

Put new text under old text. Click here to start a new topic. New to Wikipedia? Welcome! Learn to edit; get help. Assume good faith Be polite and avoid personal attacks Be welcoming to newcomers Seek dispute resolution if needed

	This template does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:
Medicine This template is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine

• Gumireddy, Kiranmai; Pazoles, Christopher; Vulfson, Evgeny; Huang, Qihong (1 May 2009). "Abstract #1807: Inhibition of tumor cell invasion and ErbB2/PI3K signaling pathways by the glutathione disulfide-mimetic NOV-002". Cancer Research. 69 (9 Supplement): 1807–1807. ISSN 0008-5472.
• Townsend, D. M.; He, L.; Hutchens, S.; Garrett, T. E.; Pazoles, C. J.; Tew, K. D. (15 April 2008). "NOV-002, a Glutathione Disulfide Mimetic, as a Modulator of Cellular Redox Balance". Cancer Research. 68 (8): 2870–2877. doi:10.1158/0008-5472.CAN-07-5957.
• Townsend, Danyelle M; Pazoles, Christopher J; Tew, Kenneth D (12 June 2008). "NOV-002, a mimetic of glutathione disulfide". Expert Opinion on Investigational Drugs. 17 (7): 1075–1083. doi:10.1517/13543784.17.7.1075.
• Krasner, C. N.; Seiden, M. V.; Penson, R. T.; Roche, M.; Kendall, D. L.; Young, J.; Matulonis, U. A.; Pereira, L.; Berlin, S. T. (20 May 2008). "NOV-002 plus carboplatin in platinum-resistant ovarian cancer". Journal of Clinical Oncology. 26 (15_suppl): 5593–5593. doi:10.1200/jco.2008.26.15_suppl.5593.

Bixbyte (talk) 20:57, 12 October 2009 (UTC)(Note: Edited by 2A00:23C5:E06:701:E:5BAC:89C4:93BB (talk) 09:16, 31 August 2018 (UTC))[reply]

Totally irrelevant to this template... 2A00:23C5:E06:701:E:5BAC:89C4:93BB (talk) 09:23, 31 August 2018 (UTC)[reply]